Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Ory

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
The Canadian Journal of Urology|April 26, 2020
Cavernous hemangioma of the adrenal gland mimicking a hepatic hemangiomaDanielle Anne Jenkins, Jesse Ory, Tarek Rahmeh, et al.
The World Journal of Men'S Health|January 21, 2021
Clinical Update on Home Testing for Male FertilityDaniel Gonzalez, Manish Narasimman, Jordan C Best, et al.
The Journal of Sexual Medicine|April 13, 2022
Evaluation of Bacteria in a Novel In Vitro Biofilm Model of Penile ProsthesisManish Narasimman, Jesse Ory, Sara Schesser Bartra, et al.
The Journal of Urology|August 27, 2021
The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized TrialsSirpi Nackeeran, Taylor Kohn, Daniel Gonzalez, et al.
The Journal of Urology|January 9, 2024
Reply by AuthorsTaylor P Kohn, Pranjal Agrawal, Jesse Ory, et al.
The Journal of Urology|November 10, 2023
Rises in Hematocrit Are Associated With an Increased Risk of Major Adverse Cardiovascular Events in Men Starting Testosterone Therapy: A Retrospective Cohort Claims Database AnalysisTaylor P Kohn, Pranjal Agrawal, Jesse Ory, et al.
World Journal of Urology|August 26, 2021
Persistent use of medical therapy after surgery for lower urinary tract symptoms: a retrospective database analysisJesse Ory, Sirpi Nackeeran, Quinn Rainer, et al.
The Journal of Urology|January 20, 2022
Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of TherapyJesse Ory, Sirpi Nackeeran, Navin C Balaji, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 7, 2021
Urological outcomes in nonagenarians with prostate cancerJosh White, Jesse Ory, Heather Morris, et al.
The Journal of Urology|May 2, 2016
Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic OutcomesJesse Ory, Ryan Flannigan, Colin Lundeen, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
The Canadian Journal of Urology|April 26, 2020
Cavernous hemangioma of the adrenal gland mimicking a hepatic hemangiomaDanielle Anne Jenkins, Jesse Ory, Tarek Rahmeh, et al.
The World Journal of Men'S Health|January 21, 2021
Clinical Update on Home Testing for Male FertilityDaniel Gonzalez, Manish Narasimman, Jordan C Best, et al.
The Journal of Sexual Medicine|April 13, 2022
Evaluation of Bacteria in a Novel In Vitro Biofilm Model of Penile ProsthesisManish Narasimman, Jesse Ory, Sara Schesser Bartra, et al.
The Journal of Urology|August 27, 2021
The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized TrialsSirpi Nackeeran, Taylor Kohn, Daniel Gonzalez, et al.
The Journal of Urology|January 9, 2024
Reply by AuthorsTaylor P Kohn, Pranjal Agrawal, Jesse Ory, et al.
The Journal of Urology|November 10, 2023
Rises in Hematocrit Are Associated With an Increased Risk of Major Adverse Cardiovascular Events in Men Starting Testosterone Therapy: A Retrospective Cohort Claims Database AnalysisTaylor P Kohn, Pranjal Agrawal, Jesse Ory, et al.
World Journal of Urology|August 26, 2021
Persistent use of medical therapy after surgery for lower urinary tract symptoms: a retrospective database analysisJesse Ory, Sirpi Nackeeran, Quinn Rainer, et al.
The Journal of Urology|January 20, 2022
Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of TherapyJesse Ory, Sirpi Nackeeran, Navin C Balaji, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 7, 2021
Urological outcomes in nonagenarians with prostate cancerJosh White, Jesse Ory, Heather Morris, et al.
The Journal of Urology|May 2, 2016
Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic OutcomesJesse Ory, Ryan Flannigan, Colin Lundeen, et al.
Pageof 6